Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.
Clin Cancer Res
; 22(7): 1572-82, 2016 Apr 01.
Article
in En
| MEDLINE
| ID: mdl-26660519
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyrimidines
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Protein Kinase Inhibitors
/
Tumor Microenvironment
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Aged80
Language:
En
Journal:
Clin Cancer Res
Year:
2016
Document type:
Article